Skip to content
Search

Latest Stories

Wolverhampton pharmacist sentenced for Covid-19 grant fraud

The Pharmacist submitted eight grant applications containing “fake quotations” to the Relight Programme, seeking a total of £40,000 in funding.

Wolverhampton pharmacist Sundip Gill convicted for Covid-19 grant fraud

Pharmacist jailed for submitting “fake quotations” in Covid-19 grant applications

gettyimages

Sundip Gill, a registered pharmacist from Wolverhampton, has been sentenced to imprisonment after being found guilty of fraud related to Covid-19 grant applications.

According to the City of Wolverhampton Council, Gill made “false representations” and supplied “fake quotations” to support funding applications.


Gill is the director of two pharmaceutical companies, Sync Chem Ltd and Collateral Ltd, and operates four pharmacy businesses in Wolverhampton—Collateral, Your Pharmacy First, Low Hill Pharmacy, and Fallings Park Pharmacy.

During the Covid-19 pandemic, the government introduced grants to support local businesses.

As part of this initiative, the City of Wolverhampton Council launched the Relight Programme and allocated extra funding to help businesses improve their premises and increase carbon efficiency.

Businesses could apply for two grants and, if they met the qualifying criteria, could receive up to £5,000 for each successful application.

According to the council, Gill submitted eight grant applications to the programme and had the potential to receive a total of £40,000.

However, the council’s Counter Fraud Team were alerted to “discrepancies with the quotations” supplied by Gill.”

Upon investigations, it was discovered that Gill had submitted “fake quotations in support of his grant applications,” the council said.

“Following a detailed investigation, Gill was charged with 18 offences of dishonesty and Sync Chem Ltd and Collateral Ltd were charged with six offences of dishonesty, all under sections 1, 2 and 7 of the Fraud Act 2006,” it stated.

Gill denied the charges but was subsequently found guilty on all counts at Dudley Magistrates Court on 21 February.

He was sentenced to 20 weeks imprisonment, suspended for 12 months, ordered to complete 200 hours of unpaid work within a year. Additionally, he was ordered to pay £3,000 in costs and a £128 victim surcharge.

His two companies, Sync Chem Ltd and Collateral Ltd, were fined £14,690 and £8,690 respectively.

“You have been convicted for being fully involved in fraud and your attempts to exploit a system to assist legitimate businesses,” district judge Graham Wilkinson told Gill during sentencing.

He added that Gill had shown “no remorse.”

Councillor Louise Miles, cabinet member for resources at the City of Wolverhampton Council, condemned the abuse of the scheme, stating: “The Relight Programme was designed to support local business through, and to recover from, the Covid-19 pandemic, and not to be abused in the way that it was by Sundip Gill.”

She reaffirmed the council’s “zero tolerance” policy towards public sector fraud.

“It is far from a victimless crime, and its impacts ripple through our society, affecting every individual and the services we all rely on, and we will not hesitate to take action in instances like this,” she added.

More For You

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
join RPS by February 2025 for SRV

For the resolution to pass, two-thirds of participating members must vote in favour.

Renew membership to vote on Royal College status - RPS urges pharmacists


The Royal Pharmaceutical Society (RPS) is urging pharmacists to renew their membership by 28 February 2025 or join by this date to be eligible for the upcoming Special Resolution Vote (SRV) on its proposed transition to The Royal College of Pharmacy.

Keep ReadingShow less